Now that dupilumab has received formal FDA approval for use in the 6-11 age group, can you share what your clinical experience has been using this biologic in the pre-adolescent, pediatric age group?

Now that dupilumab has received formal FDA approval for use in the 6-11 age group, can you share what your clinical experience has been using this biologic in the pre-adolescent, pediatric age group?

Now that dupilumab has received formal FDA approval for use in the 6-11 age group, can you share what your clinical experience has been using this biologic in the pre-adolescent, pediatric age group?


Created by

CMEducation Resources iQ&A Case-By-Case Atopic Dermatitis Medical Intelligence Zone

Presenter

Mark Lebwohl, MD

Mark Lebwohl, MD

Professor and Chairman, Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York USA